Patents Assigned to 280 Bio, Inc.
  • Publication number: 20240158408
    Abstract: Disclosed is a nitrogen-containing heterocyclic compound, pharmaceutical compositions thereof and use thereof. The present disclosure provides a nitrogen-containing heterocyclic compound represented by formula I, a pharmaceutically acceptable salt thereof, a solvate thereof, a solvate of pharmaceutically acceptable salt thereof, a crystal thereof, a stereoisomer thereof, a tautomer thereof or an isotopically labeled compound thereof. The nitrogen-containing heterocyclic compound represented by formula I is expected to treat and/or prevent various PI3K-meditated diseases.
    Type: Application
    Filed: September 11, 2023
    Publication date: May 16, 2024
    Applicant: 280 Bio, Inc.
    Inventors: Zusheng XU, Lin XIA, Xiangqian LI, Haoran YANG
  • Publication number: 20230391785
    Abstract: Disclosed is a nitrogen-containing heterocyclic compound, a method for preparing the same and a use of the same. The present disclosure provides a nitrogen-containing heterocyclic compound of formula I, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, a tautomer thereof or an isotopically labeled compound thereof, and the nitrogen-containing heterocyclic compound is expected to treat and/or prevent various RAS-related diseases.
    Type: Application
    Filed: May 23, 2022
    Publication date: December 7, 2023
    Applicant: 280 Bio, Inc.
    Inventors: Zusheng XU, Yangtong LOU, Jian SHEN, Tiegang XIE, Qingrui SUN, Li CHEN, Kun ZENG, Xin JIN
  • Publication number: 20230278998
    Abstract: Disclosed is a five-membered heteroaromatic ring structure containing compound, pharmaceutical compositions thereof and applications thereof. The present disclosure provides a five-membered heteroaromatic ring structure containing compound of formula I, pharmaceutical compositions thereof and applications thereof and the five-membered heteroaromatic ring structure containing compound is expected to treat and/or prevent various PARG-related diseases.
    Type: Application
    Filed: March 6, 2023
    Publication date: September 7, 2023
    Applicant: 280 Bio, Inc.
    Inventors: Zusheng XU, Yangtong LOU, Tiegang XIE, Linlin XU, Li CHEN, Yanhang LIU, Qingrui SUN
  • Publication number: 20230242552
    Abstract: Disclosed is a nitrogen-containing heterocyclic compound, a preparation method therefor and use thereof. The present disclosure provides a nitrogen-containing heterocyclic compound of formula I, a pharmaceutically acceptable salt thereof, a stereoisomer thereof, a tautomer thereof or an isotopically labeled compound thereof, and the nitrogen-containing heterocyclic compound is expected to treat and/or prevent various RAS-related diseases.
    Type: Application
    Filed: January 27, 2023
    Publication date: August 3, 2023
    Applicant: 280 Bio, Inc
    Inventors: Zusheng XU, Yangtong LOU, Qingrui SUN, Tiegang XIE, Jian SHEN, Xin JIN